Armed Forces Hospitals Southern Region
Khamis Mushait, 62411, Saudi Arabia
NCT Number: NCT05559957
Oligohydramnios happens in 1-5% of term pregnancies. The clinical significance of isolated oligohydramnios been a matter of debate. We aimed in this study to investigate the impact of isolated oligohydramnios on the mode of delivery and risk of adverse perinatal outcome.
Looking for future studies?
Notify Me18 year–50 year
Female
Observational
Khamis Mushait, 62411, Saudi Arabia
Retrospective study conducted in Armed Forces Hospitals of Southern Region, comparing cases with oligohydramnios (amniotic fluid level index <5) to normal amniotic fluid cases (amniotic fluid level index ≥ 8). Primary outcomes are the mode of delivery and adverse perinatal outcomes (including mortality, NICU admission, low Apgar score and sepsis)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MONITORING THE DELIVERY MODE EITHER CESAREAN OR VAGINAL, BESIDE THE NEONATAL OUTCOME AND MORBIDITIES IN BOTH GROUPS
Time frame: through study completion, an average of 1 year
Either vaginal delivery or cesarean section
Time frame: through study completion, an average of 1 year
Risk of low Apgar score, transient tachypnea of newborn, ICU admission, etc
Time frame: through study completion, an average of 1 year
Comparing incidence of labor induction between both groups and between gestational age groups
Zagazig University
Other Gov
Isolated Oligohydramnios is Associated With Less Favorable Delivery and Composite Neonatal Outcomes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05332015
Female Urogenital Diseases and Pregnancy Complications, Oligohydramnios
Antalya, Muratpaşa, Turkey (Türkiye)
View Trial DetailsNCT05059093
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Casablanca, Morocco
View Trial DetailsNCT03935607
Female Urogenital Diseases and Pregnancy Complications, Oligohydramnios
Haifa, Israel
View Trial DetailsNCT01990690
Female Urogenital Diseases and Pregnancy Complications, Oilgohydramnios
Asyut, Egypt
View Trial Details